Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Urogenital Neoplasms 1Ovarian Neoplasms 1Ovarian Diseases 1Ovarian Cysts 1Neoplasms 1Gonadal Disorders 1Genital Neoplasms, Female 1Genital Diseases, Female 1Endocrine System Diseases 1Endocrine Gland Neoplasms 1Disease 1Cysts 1Adnexal Diseases 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diffusion × Clear all
NCT02836275 2020-04-14

IOTA-MRI

KU Leuven

Phase NA Unknown
250 enrolled
Gynecologic

Adnexal Diseases, Cysts, Disease, Endocrine System Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Gonadal Disorders, Neoplasms, Ovarian Cysts, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡